In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors

By Bratoeff Eugene   Sánchez Araceli   Arellano Yazmín   Heuze Yvonne   Soriano Juan   Cabeza Marisa  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 6, 2013-12 ,pp. : 1247-1254

Informa Healthcare

Access to resources Recommend Favorite

Transcriptional regulation of the mouse steroid 5α-reductase type II gene by progesterone in brain

By Matsui D.   Sakari M.   Sato T.   Murayama A.   Takada I.   Kim M.   Takeyama K-i.   Kato S.  

Nucleic Acids Research, Vol. 30, Iss. 6, 2002-03 ,pp. : 1387-1393

Oxford University Press

Access to resources Recommend Favorite

6-Substituted 3,4-Dihydro-naphthalene-2-carboxylic Acids: Synthesis and Structure-Activity Studies in a Novel Class of Human 5α Reductase Inhibitors

By Baston Eckhard   Salem Ola I.A.   Hartmann Rolf W.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 17, Iss. 5, 2002-01 ,pp. : 303-320

Informa Healthcare

Access to resources Recommend Favorite

Biocatalytic synthesis of 4-pregnen-20,21-diol-3-one, a selective inhibitor of human 5α-reductase type II

By Hannemann Frank   Bernhardt Rita   Jose Joachim  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 22, Iss. 5, 2007-10 ,pp. : 570-576

Informa Healthcare

Access to resources Recommend Favorite

17β-N-arylcarbamoylandrost-4-en-3-one Derivatives as Inhibitors of the Enzymes 3α-Hydroxysteroid Dehydrogenase and 5α-Reductase

By  

Current Enzyme Inhibition, Vol. 14, Iss. 1, 2018-03 ,pp. : 36-50

Bentham Science Publishers

Access to resources Recommend Favorite